Focus
Is Immunity to malaria really short-lived?

https://doi.org/10.1016/0169-4758(92)90174-ZGet rights and content

Abstract

Protection against Plasmodium falciparum malaria is usually considered to be the cumulative product o f repeated exposure to parasites, and thus a function of age, in endemic areas. The recent outbreak of malaria in the central highlands of Madagascar gave Philippe Deloron and Claire Chougnet the opportunity to compare the incidence of malaria in children and young adults exposed to malaria for the first time, with that in older adults who spent their childhood in the study area before malaria control was introduced. Protection, as well as immune responses to two major P. falciparum antigens, was not related to age. Individuals older than 40 years were more protected than were younger adults. This increased protection was probably due to immunological memory.

References (21)

  • J.P. Lepers

    Lancet

    (1988)
  • C. Chougnet

    Immunol. Lett.

    (1990)
  • F. Esposito

    Trans. R. Soc. Trop. Med. Hyg.

    (1988)
  • K. Marsh

    Trans. R. Soc. Trop. Med. Hyg.

    (1989)
  • E.M. Riley

    Trans. R. Soc. Trop. Med. Hyg.

    (1991)
  • M. Razanamparany

    Arch. Inst. Pasteur Madagascar

    (1989)
  • J.P. Lepers

    Bull. WHO

    (1990)
  • P. Astagneau

    Am. J. Epidemiol.

    (1991)
  • D. Fontenille

    Am. J. Trop. Med. Hyg.

    (1990)
  • C. Chougnet

    Am. J. Trop. Med. Hyg.

    (1990)
There are more references available in the full text version of this article.

Cited by (69)

  • Malaria (Plasmodium Species)

    2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
  • Epidemiology of imported malaria give support to the hypothesis of 'long-term' semi-immunity to malaria in sub-Saharan African migrants living in France

    2014, Travel Medicine and Infectious Disease
    Citation Excerpt :

    Our results support our hypothesis of ‘long-term’ semi-immunity to malaria in VFR. They are consistent with the data from several field studies conducted in populations living in malarial transmission zones [26–28] and with a major prospective observational study of imported malaria [23]. Our hypothesis is also supported by data from an immunological study conducted ex vivo which showed the persistence of a cellular and humoral response to peptide antigens from P. falciparum in West-African migrants residing in France for more than 13 years, without any return to their country of origin [29].

  • Long-term protection against malaria after experimental sporozoite inoculation: An open-label follow-up study

    2011, The Lancet
    Citation Excerpt :

    The induction and persistence of clinical immunity against mild disease and parasitological immunity is more controversial, because of the great diversity in malaria transmission intensity, age, genetic background, and study endpoints, complicating the interpretation.5 Protective immunity to clinical malaria can be acquired rapidly,5 and, in settings of epidemic malaria, some measure of clinical protection might be sustained over several years.18 However, meta-analyses of intermittent preventive treatment studies in naturally exposed infants and children show renewed susceptibility after discontinuation of the intervention,19 and a historical review of patients treated for neurosyphilis by repeated artificial malaria infection showed no sterile protective immunity against subsequent rechallenge.20

View all citing articles on Scopus
View full text